|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 0,5410 EUR | +1,88% |
|
+5,87% | -64,78% |
| 13/07 | AB Science staakt drie klinische studies met masitinib | MT |
| 10/07 | AB Science rationaliseert portefeuille en focust op twee moleculen |  |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,88% | +5,87% | -30,64% | -48,77% | -64,78% | -62,11% | -85,87% | -96,22% | -95,92% | 49,8 mln. | |
| +0,32% | -0,66% | +3,85% | +16,08% | +23,69% | +64,21% | +23,67% | +69,38% | +121,96% | 322 mld. | |
| +0,21% | +2,87% | -0,93% | +30,08% | +16,76% | +33,60% | -10,34% | -17,09% | +43,90% | 71,6 mld. | |
| -0,91% | +0,74% | +7,18% | +29,05% | +22,64% | +39,85% | +95,22% | +99,71% | +701,36% | 9,79 mld. | |
| -3,60% | -2,43% | -0,39% | +6,70% | +1,09% | -1,16% | -6,92% | -28,14% | +44,81% | 8,39 mld. | |
| +1,80% | -1,99% | -8,88% | -20,92% | -36,60% | -15,78% | -12,22% | -33,61% | - | 4,3 mld. | |
| -0,68% | -1,87% | +4,26% | -19,76% | -34,61% | -34,78% | +3,04% | +38,13% | +80,69% | 3,81 mld. | |
| +3,08% | -1,41% | -15,38% | +10,70% | +23,15% | -12,94% | +9,52% | -30,23% | - | 3,58 mld. | |
| -2,15% | -3,40% | -5,86% | -6,73% | -10,20% | +25,70% | +40,83% | +69,50% | +100,86% | 2,59 mld. | |
| +0,85% | +9,88% | -0,42% | -11,31% | -12,37% | -0,25% | -7,32% | +72,66% | - | 2,25 mld. | |
| -.--% | +4,37% | +7,41% | -7,82% | -12,48% | -22,39% | -17,54% | -4,74% | -39,72% | 1,76 mld. | |
| +1,97% | -6,17% | -7,03% | -15,52% | -9,45% | -29,35% | +18,02% | -32,31% | - | 1,74 mld. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1,64 mld. | |
| -5,32% | +8,99% | +26,73% | +60,62% | +174,51% | +228,52% | +1.546,10% | +803,11% | - | 1,27 mld. | |
| +15,69% | +9,46% | -4,22% | -32,73% | -34,52% | +59,89% | +44,43% | +32,68% | +498,98% | 1,26 mld. | |
| +1,59% | -2,26% | -14,94% | -34,40% | -22,74% | -53,23% | -30,85% | - | - | 1,1 mld. | |
| -2,97% | -3,43% | +1,24% | -5,44% | -12,15% | -7,26% | +17,05% | +81,96% | +65,59% | 1,06 mld. | |
| +2,91% | -10,88% | -33,43% | -15,43% | -1,94% | -17,79% | +61,64% | -6,00% | - | 982 mln. | |
| +1,77% | +7,11% | +1,64% | -17,94% | -20,94% | -36,23% | -74,96% | -82,86% | - | 913 mln. | |
| +1,26% | +2,98% | +2,11% | -14,79% | -12,95% | -41,97% | -12,32% | -44,75% | -66,15% | 866 mln. | |
| Gemiddelde | +0,88% | -0,53% | -3,56% | -5,17% | -1,26% | +6,13% | +84,27% | +49,51% | +132,39% | 22,03 mld. | |
| Gewogen gemiddelde per kap. | +0,25% | -0,13% | +2,57% | +16,86% | +20,18% | +53,25% | +22,36% | +52,59% | +120,02% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
